Cargando…
Comments to “Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure”
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721204/ https://www.ncbi.nlm.nih.gov/pubmed/29238370 http://dx.doi.org/10.11909/j.issn.1671-5411.2017.10.011 |
_version_ | 1783284769440661504 |
---|---|
author | Cosansu, Kahraman Üreyen, Çağın Mustafa |
author_facet | Cosansu, Kahraman Üreyen, Çağın Mustafa |
author_sort | Cosansu, Kahraman |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5721204 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Science Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57212042017-12-13 Comments to “Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure” Cosansu, Kahraman Üreyen, Çağın Mustafa J Geriatr Cardiol Letter to the Editor Science Press 2017-10 /pmc/articles/PMC5721204/ /pubmed/29238370 http://dx.doi.org/10.11909/j.issn.1671-5411.2017.10.011 Text en Institute of Geriatric Cardiology http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission. |
spellingShingle | Letter to the Editor Cosansu, Kahraman Üreyen, Çağın Mustafa Comments to “Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure” |
title | Comments to “Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure” |
title_full | Comments to “Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure” |
title_fullStr | Comments to “Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure” |
title_full_unstemmed | Comments to “Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure” |
title_short | Comments to “Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure” |
title_sort | comments to “neutrophil-to-lymphocyte ratio compared to n-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721204/ https://www.ncbi.nlm.nih.gov/pubmed/29238370 http://dx.doi.org/10.11909/j.issn.1671-5411.2017.10.011 |
work_keys_str_mv | AT cosansukahraman commentstoneutrophiltolymphocyteratiocomparedtonterminalprobrainnatriureticpeptideasaprognosticmarkerofadverseeventsinelderlypatientswithchronicheartfailure AT ureyencagınmustafa commentstoneutrophiltolymphocyteratiocomparedtonterminalprobrainnatriureticpeptideasaprognosticmarkerofadverseeventsinelderlypatientswithchronicheartfailure |